Dr. Thanushree Naidoo

Thanushree Naidoo is a South African clinician-researcher in pediatric oncology whose work centers on improving cancer outcomes in resource-constrained settings. Affiliated with collaborative national oncology initiatives, her scholarship advances harmonized treatment protocols and equitable access to care. Her research reflects a strong commitment to children and adolescents affected by Hodgkin lymphoma and to strengthening multicenter collaboration across South Africa.

Her recent studies highlight leadership in developing and evaluating a harmonized, risk-adapted protocol for pediatric classical Hodgkin lymphoma, demonstrating improved survival across HIV status groups. She has also explored pragmatic innovations, including machine learning models based on affordable blood tests to predict treatment response where advanced imaging is limited, underscoring expertise in translational, data-informed oncology tailored to low-resource contexts.

Earlier contributions include participation in phase III trials investigating modulated electro-hyperthermia for cervical cancer, with attention to safety, quality of life, and outcomes in HIV-positive populations. Additional work on barriers to protocol harmonization and rare pediatric tumors illustrates a broad interest in health systems strengthening and underserved malignancies. This profile is based on a limited but thematically coherent body of publications.